Drug Safety Newsletter 46th Edition
03 May 2012
Topics covered in this edition of the newsletter include:
- Proton-pump inhibitors - Association with hypomagnesaemia with long term use
- Metoclopramide - New recommendations for treatment of children
- Gonadotrophin-releasing hormone agonists - Risk of depression
- HMG-CoA reductase inhibitors - Risk of new onset diabetes in patients already at increased risk of developing diabetes
- Varenicline (Champix) and cardiovascular safety
- Adverse drug reaction reporting experience during 2010
- Adverse reaction and quality defect reporting including herbal medicines
Drug Safety Newsletter 46th Edition